Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene in advanced breast cancer
NCT00003752Phase 2Completed
- Sponsor
- Ligand Pharmaceuticals
- Start
- Oct 1998
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in breast cancer, sponsored by Ligand Pharmaceuticals. Started Oct 1998; status: completed.
02
Drugs
bexarotene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003752.